Azienda Sanitaria Locale Roma E Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2012
NCT03018535
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glomerulonephritis (Phase 3)

Glomerulonephritis, Membranous (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 3